Reference results for Reslizumab from Search.com.

Reslizumab - Wikipedia, the free encyclopedia

https://en.wikipedia.org/wiki/Reslizumab

Reslizumab (trade name Cinquil) is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and ...

Profile of reslizumab in eosinophilic disease and its ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3544267

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

Reslizumab « New Drug Approvals

newdrugapprovals.org/2013/11/13/reslizumab

Reslizumab(CINQUIL) is a humanized monoclonal antibody targeted against IL-5 that is being developed by Cephalon for the treatment of eosinophilic asthma.

Teva's Reslizumab Delivers Clinically and Statistically ...

www.fiercebiotech.com/press-releases/tevas-reslizumab-delivers...

Teva's Reslizumab Delivers Clinically and Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase III Studies

reslizumab (Cinquil) UKMi New Drugs Online Database

www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5261

Trade Name: Cinquil : Entry Type: New molecular entity : Development and Regulatory status: UK: Pre-registration (Filed) EU: Pre-registration (Filed) US:

Reslizumab, a humanized anti-IL-5 mAb for the treatment of ...

www.ncbi.nlm.nih.gov/pubmed/19479666

1. Curr Opin Mol Ther. 2009 Jun;11(3):329-36. Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions.

reslizumab - Wiktionary

https://en.wiktionary.org/wiki/reslizumab

reslizumab. Definition from Wiktionary, the free dictionary. Jump to: navigation, search. English Etymology -li-+‎ -zu-+‎ -mab. Noun . reslizumab ‎ ...

Efficacy and Safety Study of Reslizumab to Treat ...

https://clinicaltrials.gov/ct2/show/NCT00538434

Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects ... of reslizumab versus ... Eosinophilic Esophagitis in Subjects Aged 5 ...

Teva Announces FDA Acceptance of the Biologics License ...

www.tevapharm.com/news/teva_announces_fda_acceptance_of_the...

Teva Announces FDA Acceptance of the Biologics License Application for Reslizumab. Investigational Biologic for the Treatment of Inadequately Controlled Asthma in ...

Reslizumab for inadequately controlled asthma with ...

www.thelancet.com/journals/lanres/article/PIIS2213-2600(15)00042-9...

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo ...